Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > bad news, really bad news
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Lemersonon Sep 28, 2016 2:36am
152 Views
Post# 25284630

RE:bad news, really bad news

RE:bad news, really bad news
TSX2016 wrote: https://www.medicines.org.uk/emc/PIL.29265.latest.pdf

Trazodone is actually bought from focus pharma and their address is the same as the headquater of AMOc. Longs are fxxxed.....More fees to pay to Cinven.


ummm Amco bought focus pharma in 2014
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities